C erebral aneurysms (CAs) are dilations of cerebral arteries that affect 2%-5% of the population. 35 Although most of these lesions are clinically unapparent, CA rupture and subarachnoid hemorrhage usually occur between 40 and 60 years of age. Therefore, early identi fication of a CA is essential for preventing subsequent bleeding events, which often lead to substantial morbidity and mortality. 4, 16 The pathogenesis of CA formation and rupture is complex and seems to arise from multiple factors. A familial predispositionisthestrongestriskfactorforthedevelopment of a CA; siblings of patients with CA are at a 4-fold increased risk of hemorrhage, 40 suggesting a significant genetic component to CA pathogenesis.
rupture of CAs. 10, 11, 17, 26, 37 Thedevelopmentandruptureof aneurysmsinvolvelocaldegradationofvascularstructuralproteinsandremodelingofthediseasedbloodvessels. Elastin and collagens are major structural components of the vascular wall, and it has been suggested that elastinolysis is particularly pertinent to vessel dilation, while collagenolysis relates to aneurysm rupture. 45 Inrecentyears,compellingevidencehasindicatedthat a number of matrix metalloproteinases (MMPs), which possess proteolytic activity against extracellular matrix proteins such as elastin and collagens, play an important roleinthediseaseetiopathologyofvarioustypesofaneurysms. 45 Although the genetic basis of CA is poorly understood, the identification of susceptible genetic variants may increase our understanding of CA formation and rupture mechanisms.Extensivegeneticassociationstudiesareurgently needed to elucidate the molecular pathogenesis of CAs. 46 In recent years, candidate gene association studies havebeenthemostcommonapproachtoidentifysusceptibilitygenesforcomplexdiseasessuchasCA.However, our ability to identify relevant candidates is generally restricted by our understanding of disease pathophysiology, which in many cases is limited. For CA, several physiological pathways, including inflammation, 5, 15, 33, 36 disruption of the extracellular matrix surrounding the arterial wall, 38 andnumerousheritableconnectivetissue disorders, 39 havebeenimplicatedindiseaseoccurrence. However,theconventionalcandidategeneapproachhas been widely disappointing for CA, and most findings have not been replicated. 21, 29 Once MMP participation in vascular remodeling became apparent, researchers proposedthatvariationsinMMP may play a role in CA pathogenesis. 12, 21, 24 In addition, subsequent results from a genome-wide association study (GWAS) for pediatric stroke patients have highlighted a crucial role for various ADAMTS (A-disintegrin and metalloproteinase with thrombospondin motifs) metalloproteinases in disease pathophysiology. 1 The ADAMTS proteins are members of a metalloprotease family that contain the thrombospondin type 1 sequence repeat motifs common to extracellular matrix proteins. 27 Members of the ADAMTS family play a role in extracellularmatrixdegradationandareinvolvedinseveral other biological processes, including coagulation, angiogenesis, and cell migration. 13 Variations within several ADAMTSgeneshavebeenimplicatedinprothrombotic, 13 inflammatory, 22, 28 and connective tissue diseases, 42 suggesting a potential role in CA pathogenesis. 18 Together, thesefindingssuggestthatADAMTS genes may be excellentscreeningcandidatesforCApathogenesis;however, to our knowledge, it remains unknown if and where these genes act on disease susceptibility.
ToaddresswhethervariationsinADAMTS genes are geneticdeterminantsofCAs,weanalyzed8variantsof4 ADAMTSgenesassociatedwithdiversevascularphenotypes in 353 patients with CAs and 1055 healthy adults, all from Northwest Germany.
methods patients
Our study included 258 patients harboring a CA who weretreatedattheDepartmentofNeurosurgery,University Hospital Muenster. From these 258 patients, we identified222probands(79.4%withrupturedaneurysmsand 20.6% with unruptured aneurysms) who were considered eligible for genotyping after assessment of DNA quality. All study participants were investigated with respect to clinical parameters. To enhance the power of our study, we also included in our analysis 131 CA patients who experienced either subarachnoidal bleeding (SAB) or intracerebral bleeding (ICB) from a 2010 independent genetic association study initiated at the Institute of Epidemiology and Social Medicine in Muenster. In all patients (9.07% of whom had multiple aneurysms), the diagnosis of CA was made using cerebral digital subtraction angiographyandconfirmedatsurgery.Healthyadultsserved as the control group (n = 1055) and were recruited from the population-based Dortmund Health Study, which was conducted in the same region. 31, 41, 43 All recruitment and research protocols were reviewed and approved by theinstitutionalreviewboardoftheUniversityofMuenster, and written informed consent was obtained from all study participants.
single Nucleotide polymorphism selection, genotyping, and Quality control DNA was extracted from peripheral blood using standard methods. For genotyping, we selected 8 single nucleotide polymorphisms (SNPs) recently shown to be associated with pediatric stroke (rs469568, rs11750568, rs1364044), 1 ischemic stroke (rs2285489, rs739469, rs2301612, rs4962153), 13 and myocardial infarction (rs4380028; Table 1) . 34 For genotyping, we used 2 ng genomic DNA and Taqman SNP Genotyping Assays (Applied Biosystems, Inc.), following the manufacturers' instructions.
Genotypingefficiencywas>98%,andalleleidentification was performed manually using SDS2.3 software. All laboratory analyses were performed at the Institute of Arteriosclerosis Research in Muenster.
All patients in the control group were already genotypedusingtheInfiniumHD2.5MOmniChip(Illumina, Inc.) and analyzed with GenomeStudio. For SNPs with no directlygenotypeddataavailable,weinputtedgenotypes using the genome-analysis software PLINK V 1.06. 32 To ensure the comparability of our results, we replicatedthegenotypingofallvariantsandshowedasignificant association with CA using Taqman SNP Genotyping Assays, following the manufacturers' instructions.
statistical analysis
We compared allele frequencies of the risk-associated variantsinpatientswithCAandinthecontrolgroupby using the chi-squared test, as analyzed in PLINK V1.06. We applied logistic regression models to examine the association between each SNP and the occurrence of a CA inanadditivemodelofinheritancethatincludedtesting trends across SNP categories. All models were adjusted for age and sex. Since 8 SNPs were genotyped, we used thefalsediscoveryratecontrolmethodtocorrectformultiple testing, which was analyzed with PLINK V1.06.
results
TodetermineifgeneticvariationswithintheADAMTS familycouldaffectapatient'ssusceptibilityfordeveloping a CA, we analyzed 8 polymorphisms within 4 ADAMTS genes in 353 patients with CA and in 1055 adults in the control group.
Women represented the majority of patients (67%), and wefoundnosignificantdifferencesinmeanage(56.7vs 54.5 years) between the CA group and the control group. Wegenotyped8candidateSNPspreviouslyassociated with ischemic stroke, 13 myocardial infarction, 34 or pediatric stroke. 1 The allele frequencies for each SNP and the odds ratio (OR) for each genotype are reported in Table  2 .NodeviationfromtheHWEwasobservedforanyof the 8 SNPs.
Five of the 8 SNPs under investigation were significantly associated with CA after adjusting for age and sex. The ORs ranged from 0.65 to 1.31 and were similar in magnitudetothosepreviouslyreportedforpediatric 1 and ischemic 13 
20,30
Previous studies found that ADAMTS gene variants weresignificantlyassociatedwithseveralrelatedphenotypes, 1, 13, 34 resulting in this gene family becoming an attractivetargetforgeneticscreeninginpatientswithaCA.
In the current study, the largest CA risk associated with a single variant (OR 1.31, p = 0.006), was observed for carriers of the ADAMTS2 variant rs11750568, an allele previously associated with pediatric stroke.
Mutations in the ADAMTS2genehavebeenalsoconnectedtothe
Ehlers-Danlossyndrome,asevereconnectivetissuedisorder. 43, 43 Schievinkandcolleaguesproposedover20years ago that this kind of tissue disease enhances the potential fordevelopingaCA. 39 This hypothesis has been supported by more current findings, which indicate that mutations in genes that affect the integrity of the extracellular matrix surrounding the arterial wall play an important role inCAvulnerability.
3,38
Inaddition,severalbiomarkersfor connective tissue disorders have been identified that are clearly linked to CA pathogenesis. 44 Moreover, we have identified significant associations between CA susceptibility and genetic variants for 2 other members of the ADAMTS family. The ADAMTS12 variant rs1364044 seems to offer a protective effect against CA pathogenesis, while the ADAMTS13variants rs2285489andrs2301612conferasignificantriskforde-velopingCAs.
Interestingly, ADAMTS12seemstobeinvolvedinthe degradation of cartilage oligomeric matrix proteins and has been shown to possess antiangiogenic and tumor-suppressiveproperties 9 as well as a modest association with heart failure. 25 Furthermore, subsequent analysis suggested an important role for ADAMTS12ininflammatory processes. 22 Inflammation has been frequently connected to CA pathogenesis. 3, 8, 15, 33 This is primarily because extensive inflammatoryandimmunologicalreactionsarecommon in unruptured CAs and may be related to aneurysm formation and rupture. 8 These observations have been furthersupportedinfindingsbyHashimotoandcolleagues, who identified abnormal vascular remodeling mediated byinflammatorycellstobeakeypathologiccomponent of various vascular diseases. They postulated that CAs evolvefromacombinationofinflammatoryprocesses,hemodynamics,andvascularremodeling.
15
ADAMTS13, also known as von Willebrand factor cleavingprotease,isalreadyestablishedasapivotalcomponent of blood coagulation, 7 prothrombotic diseases, 13 andvascularinflammation.
6
RecentfindingsbyHansonetal.confirmanassociation between the ADAMTS13variantrs2285489andCAsus-ceptibility; 14 inapreviousstudy,thesameauthorsreported anassociationbetweenthisvariantandadecreasedriskof ischemic stroke. 13 Takentogether,ourfindingsemphasizethetheorythat geneticvariantsoftenconfersusceptibilitytomorethan1 disease and that different diseases share common pathological pathways.
Nevertheless,weareawarethatourstudyhasseveral limitations. First, the limited number of individuals included in our study (353 patients with CA and 1055 healthy controls) limits the statistical power and may increase the riskofTypeI(falsepositive)andTypeIIstatisticalerrors (missed association). This is particularly relevant given thelackofreplicationofourfindingsinanindependent cohort.However,allgeneticvariantsanalyzedinthecurrent study originated from GWAS for related phenotypes. Second,weacknowledgethatreproducingpreviousfindings for pediatric 1 and ischemic 13 stroke and myocardial infarction 34 in our study may be considered "pseudoreplication." A recent study reported an association between ADAMTS13 genetic variants and aneurysmal subarachnoid hemorrhage in 183 patients and 680 control patients, which may be considered an independent association in a comparable clinical phenotype. 14 However, additional studies with larger sample sizes are warranted to generalizeourfindings.Ideally,thesestudiesshouldalsoinclude additional clinical subphenotypes, i.e., number of aneurysms,thelocationthereof,andrelevantriskfactorssuch as smoking habits, to allow for more detailed, stratified analysisandtorefinetheobservedassociations.
conclusions
The mechanisms through which ADAMTSgenevariants lead to the development of CAs remain unknown. However, our results give rise to the hypothesis that reduced integrity of the endothelial wall, as conferred by ADAMTSgenedefects,togetherwithinflammatoryprocessesanddefectivevascularremodeling,playsanimportantroleinCApathogenesisandunderscoresthefindings frompreviousanalysestoCAsusceptibility. 3, 8, 13, 15, 38 A better understanding of how these genetic variants modulateCAvulnerabilitymayhelptoimplicateunderlying pathways, simplify disease prediction, and prevent resultantbleedingeventsbyspecificscreeningofat-risk populations.
acknowledgments
WethanktheInnovativeMedicalResearchfundoftheUniversity of Münster Medical School for supporting this work.
references

